Drug Induced Ductopenia

Slides:



Advertisements
Similar presentations
Update in Liver Disease SGNA April 4, 2014 Outline Interpretation of elevated liver chemistries Fatty liver disease Hepatitis B Hepatitis C.
Advertisements

Approach to a patient with jaundice
The Liver. Function: –Metabolism Anatomy/Histology –Right, left lobe –Biliary Tree –Components of Liver: 1. Liver Parenchyma (lobule) 2. Portal area (vessels,
Jaundice Prepared and presented by Luka Marinculić Mentor: A. Žmegač Horvat.
CIRRHOSISPathophysiology&Complications. What is Cirrhosis?
Approach to medical liver biopsies Dr Behrang Mozayani Consultant Histopathologist Southmead hospital Bristol.
Liver, Gall Bladder, and Pancreatic Disease. Manifestations of Liver Disease Inflammation - Hepatitis –Elevated AST, ALT –Steatosis –Enlarged Liver Portal.
An Approach to Abnormal LFTs Robert C. Lowe, M.D. Boston Medical Center July 17, 2013.
Department of Medicine Grand Rounds Clinical Vignette Ilana Bragin January 14 th, 2009 NYU Langone Medical Center Internal Medicine Residency Program.
Fatty Liver and Pregnancy Shahin Merat, M.D. Professor of Medicine Digestive Disease Research Institute Tehran University of Medical Sciences 1.
Cholestatic Liver Disease Primary Biliary Cirrhosis.
Cholestatic liver diseases:
Adult Medical- Surgical Nursing Gastro-intestinal Module: Liver Cirrhosis.
Primary Sclerosing Cholangitis
The ABCs of PSC Jacqueline O’Leary, MD MPH Medical Director of Research, Baylor Simmons Transplant Institute.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
Department of Medicine Grand Rounds Clinical Vignette Wednesday, March 4, 2009 Peter Shue, M.D.
Adult Medical- Surgical Nursing Gastro-intestinal Module: Jaundice.
VCU DEATH AND COMPLICATIONS CONFERENCE.  24 year old male  h/o UC diagnosed 1.5 years ago Treated with multiple agents with minimal efficacy Remicade,
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Hepatitis. Hepatitis * Definition: Hepatitis is necro-inflammatory liver disease characterized by the presence of inflammatory cells in in the portal.
CIRRHOSISPathophysiology&Complications. Normal liver functions Carbohydrate Metabolism Hypo- or hyperglycemia Fatty Acids Metabolism Lipid Transport.
From Hemobilia to Hematochezia A 49-year-old woman transferred from an outside hospital because of severe hematochezia with a drop in hemoglobin from 14.
Liver function test Ross Stringer. Synthetic function Albumin & clotting (INR/PT, APTT) Hepatocellular damage AST (aspartate aminotransferase) & ALT (alanine.
CUMC GI 82/female, Jaundice 이인석, 박재명, 오정환, 한혜원, 조유경, 김상우, 최명규, 정인식 가톨릭대학교 의과대학 내과학교실.
Evaluation of Abnormal LFT's Vinod Kurup, MD July 28, 2003 CC-BY-SA.
Benign Liver Masses in HIV Patient
Recurrent hepatitis with Halogenated Anesthetics
Eosinophilic Cholangiopathy
NASH.
Liver Disease tutoring Part 1
Missing Cirrhosis on CT Scan
Drug Induced Hepatitis
Drug Induced Hepatitis Progressing to Cirrhosis
History 24 Year old woman 6 Months of age “severe cholangitis’’ emergently decompressed via cholecystostomy tube choledochal cyst noted Definitive surgery:
Progressive Liver Failure following Gastric Bypass
CHOLESTASIS Dr Mahsa Khodadoostan
HCC.
Acute hepatitis of uncertain cause, rule out EBV related
Hemangioendothelioma
Primary biliary cirrhosis, cirrhotic stage
Case 34.
Chronic viral hepatitis type B with “ground glass” cells
Successful TACE for HCC
Fatal Liver Injury with a Food Supplement in Transplant Patient
DIAGNOSIS OF CIRRHOSIS
Wilson’s Disease.
Alcoholic cirrhosis and acute alcoholic fatty liver with cholestasis
Food Supplement associated Cholestasis
Typical Case of HCC.
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Comorbidity NASH/HCV and HCC
Orthotopic liver transplant, recurrent primary sclerosing cholangitis
Frank A. Anania, MD  The American Journal of Medicine 
Alcoholic foamy degeneration with early alcoholic cirrhosis
Acute viral hepatitis type C
Mastocytosis.
Liver “Function” Test 2013 Mini-Lecture
Chronic viral hepatitis type B and chronic delta
AFP > 9000 without demonstrable HCC
Chapter 12 Liver Transplantation 1
Chapter 3 Fatty Liver Diseases 1 Alcoholic steatosis Case 3.1.
Case 24.
Primary biliary cirrhosis, AMA negative
Scenario 13.2 Polytrauma.
Chronic Cholestasis with Dilation of Intrahepatic Bile Duct Related to Administration of Ceritinib  Taizou Hirano, MD, PhD, Mitsuhiro Yamada, MD, PhD,
CLINICAL SOLVING PROBLEM
Case # 3. Dr. Laura Lamps A 36 year old Caucasian female presented in May of 2010 with nausea and vomiting. Lab work revealed an ALT of 1600, AST of.
Case #4 Dr. Laura Lamps A 34 year old Hispanic female presented in March of last year with weight loss and tachycardia. She was found to be hyperthyroid,
Presentation transcript:

Drug Induced Ductopenia

History May 2004: 60y/o WM after 9 months of fatigue, night sweating, weight loss, hoarseness and cough: Nodular sclerosing Hodgkin’s Disease May 2004: 3 weeks of jaundice itching acholic stools

Medications: Celexa for 5 years Bextra for 5 days in the last month ASA Acetaminophen Lipitor ROS 18 months ago transient episode of skin excoriation and pruritus of the pubis and lower abdomen (tx as scabies) PMH: Subdural hematoma secondary to trauma ’97 Hypercholesterolemia Social: No smoking, no drugs 2 drinks/day (vodka or gin) Retired radiologist Family Hx: Wilson disease: cousin

Physical Examination 130/80 90x’ 12x’ 97.0F AOT3, deeply jaundice, no asterixis No jvd, small cervical adenopathy Reg S1S2, no gmr; CTAB BS+, ng/nt, no hsm, no ascites LE no edema

Laboratories 11.4 13.7 259 N 89% 37 L 3% PT 12.3 sec Glucose 110 PTT 23.2 sec Creatinine 1.2 LDH 605 AST 164 Ammonia 25 ALT 471 AMA neg Alk. Phosp. 689 ANA neg Total Bili. 18.1 Total Prot. 7.4 Albumin 3.6

Ultrasound: normal liver, no intra- or extrahepatic biliary dilatation CT: multiple mediastinal LAD, no intrabdominal abnormalities Normal MRCP

?

Biopsy 5/14/04 No evidence of Hodgkin’s disease in the liver Moderate cholestasis Mild inflammation of the biliary spaces Paucity of bile ducts

Management Given ursodiol, cholestyramine and diphenidramine Improvement in ALKP from 689 to 371; Tbil from 14.5 to 10.5 Given MOPP (meclorethamine, procarbazine and prednisone; not given oncovin–vincristine) Later in his course added fat-soluble vitamins and biphosphonates

Ursodiol and MOPP (CTX) cholestyramine LAB 5/14 5/18 6/23 7/6 8/17 8/24 10/5 11/2 AST 222 164 135 114 115 86 51 56 ALT 586 471 200 145 116 79 54 ALK 1018 689 371 508 411 378 287 316 Tbil 15.8 14.5 10.5 13.9 7.8 1.5 0.9 Dbil 6.8 TP 7.7 7.4 Alb 3.8 3.6 Plt 384 259 266 PT 12.3 13.1 INR 0.91 1.05

Biopsy 10/26/04 (5 months later with biochemical resolution) Absence of bile ducts Chronic cholestasis Acute inflammatory response Portal fibrosis, without any bridging fibrosis